Beta Bionics BBNX
NASDAQ BBNX
$17.42 -1.91 (-9.88%)
As of: Sep 9, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) Treasury Shares (2023 - 2024)

Beta Bionics' (BBNX) quarterly Treasury Shares came in at $17.2 million in Q4 2024, up 33.8% year-over-year from $12.9 million in Q1 2024, and up 33.8% quarter-over-quarter from $12.9 million in Q3 2024.

Analysis

Beta Bionics (BBNX) Treasury Shares (2023 - 2024) Analysis & Trends

Beta Bionics has disclosed Treasury Shares across 2 years of filings, most recently posting $17.2 million for Q4 2024.

  • In Q4 2024, Treasury Shares rose 33.8% year-over-year to $17.2 million; the TTM figure through Dec 2024 stood at $17.2 million (up 33.8% YoY), while the FY2024 annual figure was $17.2 million, up 33.8% from the prior year.
  • Treasury Shares came in at $17.2 million for Q4 2024 at Beta Bionics, up from $12.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $17.2 million in Q4 2024 to a low of $12.9 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 267.91 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 303.21 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 7.67 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 35.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Beta Bionics 786.45 Mn 605.96 Mn 18.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 17.23 Mn
Dec 31, 2024 17.23 Mn
Sep 30, 2024 12.88 Mn
Sep 30, 2024 12.88 Mn
Jun 30, 2024 12.88 Mn
Jun 30, 2024 12.88 Mn
Mar 31, 2024 12.88 Mn
Mar 31, 2024 12.88 Mn
Dec 31, 2023 12.88 Mn
Dec 31, 2023 12.88 Mn